PATENT CLAIM ANALYSIS

Application Number: 15896423
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "199100"]

Abstract:
Disclosed are compositions and methods of treating a neurodegenerative disease in an individual. The methods disclose administration of an Integrin α4β1, Very Late Antigen-4 positive neural precursor cell (“VLA4+ NPC”) transfected with a lentivirus overexpressing wild type GCase to an individual having a neurodegenerative disorder. The neurodegenerative disease may include lipid storage diseases, for example Gaucher disease, Parkinson's disease (PD), Dementia with Lewy bodies.

Claim (Index 2):
The method of  claim 1 , wherein said neurodegenerative disease is a lipid storage disease.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 88.0
- Lexical Diversity: 1.36842
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15399165', '14494065', '14127546', '14884503', '12384446']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7304029023402575
- 35 USC 102 Novelty (BERT): 0.511493069670294
- Combined Prediction Score: 0.7085119190732612
- Mean Citation Score: 221.888356
- Max Citation Score: 252.54108
- Similarity Product: 157.78809492872

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test